Type 2 & other diabetes

Comparative effectiveness of continuous positive airway pressure and glucagon‐like peptide‐1 receptor agonists in obstructive sleep apnea: A network meta‐analysis of randomised trials

Diabetes Obes MetabPublished Systematic review and network meta-analysis of randomised trials

Pooled result · AHIResult — go to the resultMD −22.17 events/h 95% CI −38.01 to −6.33

Authors' conclusion

CPAP is the most effective therapy for respiratory control, while GLP-1 receptor agonists primarily improve weight and glycaemic indices

Study context

Population
Adults with obstructive sleep apnea (OSA); RCTs of continuous positive airway pressure (CPAP), exenatide, liraglutide, tirzepatide or combinations (PubMed, Embase, CENTRAL through August 2025)
Participants
3,964 adults34 trials
Comparison
CPAP, GLP-1 RAs, their combination and no active intervention
Outcome
Apnea-hypopnea index (AHI)
Methodological detailsrandom-effects, SUCRA ranking, GRADE certainty assessment
  • Random-effects
  • SUCRA ranking
  • GRADE certainty assessment

Pooled result

AHI

MD

−22.17 events/h

95% CI −38.01 to −6.33

CPAPvs No active intervention
MD −22.17 events/h (95% CI −38.01 to −6.33)

As reported in the abstract

Further pooled results

OutcomeMD (95% CI)
ESSCPAPvs No active intervention−2.75 (−3.71 to −1.79)
OutcomeMD (kg/m²) (95% CI)
BMILiraglutidevs No active intervention−1.60 (−2.04 to −1.16)
BMILiraglutide plus CPAPvs No active interventionGreatest BMI reduction−2.00 (−3.49 to −0.51)
OutcomeMD (%) (95% CI)
HbA1cLiraglutidevs No active intervention−0.19 (−0.25 to −0.13)

HbA1c

CPAP showed no meaningful metabolic effect

SBP, DBP, fasting glucose

No intervention significantly changed SBP, DBP or fasting glucose

GRADE certainty of evidence

Moderate for CPAP on respiratory and sleepiness outcomes and for GLP-1 RAs on body mass index (BMI) and HbA1c; low for blood pressure and fasting glucose

Original publication

Comparative effectiveness of continuous positive airway pressure and glucagon‐like peptide‐1 receptor agonists in obstructive sleep apnea: A network meta‐analysis of randomised trials. Diabetes Obes Metab. Published 23 February 2026. doi:10.1111/dom.70572

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.